Effect of telemedicine follow-up on glycaemic control among patients with hip fracture
Published
July 26, 2024
Paper ID
PAP-000239
Status
Published
DOI
10.65712/tmj.test000497
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on telemedicine follow-up. Methods: We conducted a case series across 2 centres between 2017 and 2024. Results: 1001 participants were included (median age 34 years). Serious adverse events were rare and similar between groups. Conclusion: These findings suggest that telemedicine follow-up is associated with better glycaemic control in patients with hip fracture.
Introduction
Earlier studies of telemedicine follow-up were small or single-centre. The cost of glycaemic control to health systems is substantial.
Guidelines make only a weak recommendation on telemedicine follow-up. Practice around telemedicine follow-up varies widely between centres.
Discussion
Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols. These findings suggest that telemedicine follow-up is associated with better glycaemic control in patients with hip fracture.
Future work should test telemedicine follow-up in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Future work should test telemedicine follow-up in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
These findings suggest that telemedicine follow-up is associated with better glycaemic control in patients with hip fracture. Strengths include the sample size and blinded outcome assessment.
Conclusions
Telemedicine follow-up should be considered for patients with hip fracture to improve glycaemic control.
References
1. Nasser T, Mueller P, et al. An enhanced recovery pathway and acute kidney injury. Pediatrics. 2023;344(7):718-1177.
2. Haddad W, Nasser S, et al. Tranexamic acid and emergency department revisits. Pediatrics. 2015;202(8):479-914.
3. Dubois M, Costa G, et al. An antibiotic stewardship programme and medication adherence. Crit Care Med. 2008;95(1):198-1690.
4. Silva B, Ahmed Z, et al. Nurse-led discharge planning and health-related quality of life. Crit Care Med. 2010;324(7):234-1374.
5. Patel Z, Rahman O, et al. Machine-learning triage and length of stay. JAMA. 2013;230(10):577-932.
Appendices
Supplementary tables are available on request.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients with hip fracture.
Eligible participants were patients with hip fracture. We conducted a case series across 2 centres between 2017 and 2024.
Results
The adjusted odds ratio was 0.86 (95% CI 0.38 to 0.98). Effects were consistent across prespecified subgroups.
The adjusted odds ratio was 0.40 (95% CI 0.27 to 0.70). glycaemic control occurred in 4% of the intervention group versus 27% of controls. Effects were consistent across prespecified subgroups.
The adjusted odds ratio was 0.43 (95% CI 0.39 to 0.96). The adjusted odds ratio was 0.45 (95% CI 0.31 to 0.98).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Centre B | 144 | 10 | 21.1 | 0.56 | 0.59–1.12 |
| Age ≥ 65 | 139 | 24 | 26.3 | 0.80 | 0.49–1.21 |
| Male | 188 | 48 | 38.6 | 0.78 | 0.46–1.34 |
| Centre A | 695 | 20 | 29.4 | 0.72 | 0.57–1.38 |
| Age ≥ 65 | 211 | 8 | 4.3 | 0.40 | 0.21–1.5 |
Values are n (%) unless stated otherwise.

Shown for patients with hip fracture; error bars are 95% confidence intervals.

Shown for patients with hip fracture; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. 301 participants were included (median age 37 years).